IQVIA | Elizabeth Wilson

A Clinical Research Organisation with an unsurpassed range of clinical development services from first-in-man to Phase III to regulatory submission and post-marketing research, all powered by the IQVIA CORE, which increases efficiency and accelerates timelines. 

Commercialisation solutions to accelerate peak sales and bring new medicines to patients faster, including innovative real-world research that provides crucial evidence about the value of new medicines. 

We use our in-depth local market knowledge, globally integrated technologies, and deep domain expertise to help customers succeed. Whether you are a small biotech, a global biopharma, a consumer health company, a not-for-profit, a government agency or other, if you are involved in improving human health, IQVIA ANZ can help.

Therapeutic areas include: Cardiovascular Diseases, Congenital, Hereditary and Neonatal Diseases and Abnormalities, Digestive System Diseases, Disorders of Environmental Origin, Endocrine System Diseases, Eye Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Immune System Diseases, Male Urogenital Diseases, Mental Disorders, Musculoskeletal Diseases, Neoplasms, Nervous System Diseases, Nutritional and Metabolic Diseases, Occupational Diseases, Otorhinolaryngologic Diseases, Parasitic Diseases, Respiratory Tract Diseases, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Virus Diseases and Wounds and Injuries.

Sub-therapeutic areas include cancers and all interventional drug clinical trials in multiple therapeutic areas.

Other areas of expertise include real world evidence.